IP Library Granted Patent US 9,919,168
Granted Patent B2
US 9,919,168 · App. 12/842,734 · Granted Mar 20, 2018

Method for improvement of cellulite appearance

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,919,168
App. No.
12/842,734
Granted
Mar 20, 2018
Kind
B2
Abstract

A method and apparatus are provided for treating connective tissue. The method and apparatus includes elongating connective tissue including septa and/or fascia to achieve a lasting improvement (e.g., a long term, durable and/or substantially irreversible treatment of the connective tissue) to improve the appearance of cellulite.

Claims (16)

1. A method of improving the appearance of cellulite, the method comprising:

applying a stretching force to at least one of a septa tissue and a fascia tissue that is adjacent to fat tissue beneath a region of a subject's skin having the appearance of cellulite; and

heating at least one of the septa tissue and the fascia tissue for a period of time and at a temperature in a range of about 38° C. to about 60° C. to achieve lasting elongation of at least one of the septa tissue and the fascia tissue upon release of the stretching force.

2. The method of claim 1 wherein applying the stretching force and heating at least one of the septa tissue and the fascia tissue occur simultaneously.

3. The method of claim 1 wherein the heating of at least one of the septa tissue and the fascia tissue occurs in the presence of the previously applied stretching force.

4. The method of claim 1 wherein applying the stretching force comprises inserting fluid into the subject's tissue.

5. The method of claim 4 wherein the fluid is pre-heated to heat at least one of the septa tissue and the fascia tissue.

6. The method of claim 1 wherein one or more of radiofrequency energy, ultrasound energy, light energy, and microwave energy are employed to heat at least one of the septa tissue and the fascia tissue.

7. The method of claim 1 further comprising utilizing a cannula to apply an energy source to heat at least one of the septa tissue and the fascia tissue.

8. The method of claim 7 wherein the cannula applies one or more of radiofrequency energy, ultrasound energy, light energy, and microwave energy to at least one of the septa tissue and the fascia tissue.

9. The method of claim 1 wherein vacuum pressure applies the stretching force.

10. The method of claim 1 wherein the temperature of at least one of the septa and the fascia range from about 44° C. to about 60° C.

11. The method of claim 1 wherein the temperature of at least one of the septa and the fascia range from about 40° C. to about 48° C.

12. The method of claim 1 wherein the period of time ranges from about 10 seconds to about 60 minutes.

13. The method of claim 1 wherein the period of time ranges from about 30 seconds to about 30 minutes.

14. The method of claim 1 further comprising cooling the external surface of the region of the subject's skin.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
PARTIAL RELEASE OF SECURITY INTEREST ASSIGNMENTS RECORDED AT REEL/FRAME 042261/0911 Recorded Oct 5, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 044127/0923 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →
MERGER Recorded Jan 8, 2014
From: PALOMAR MEDICAL TECHNOLOGIES, INC.
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 031936/0704 →
MERGER Recorded Jan 2, 2014
From: PALOMAR MEDICAL TECHNOLOGIES, INC.
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 031874/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2010
From: ALTSHULER, GREGORY B.; ZENZIE, HENRY H.; GAAL, CHRISTOPHER; COHEN, RICHARD
To: PALOMAR MEDICAL TECHNOLOGIES, INC.
Reel/Frame 025234/0715 →